Intravenous Sodium Chloride Injection Recalled for Incomplete Labeling and Warnings
B. Braun Medical Inc. is recalling 43,812 bags of 0.9% Sodium Chloride Injection due to incomplete or missing labeling, including warnings and instructions for use.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall for incomplete or missing labeling on a prescription intravenous medication. Per the severity rubric, FDA Class III recalls typically score 1–2, and this minor labeling error falls under the Moderate (2) category. The source does not report any illnesses or injuries in connection with the recall.
Plain-English summary
B. Braun Medical Inc. is recalling 43,812 bags of 0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container, distributed throughout the United States. The product is a prescription intravenous medication.
The recall is due to incomplete or missing labeling on affected lots. The product description, warnings, storage information, and instructions for use are either missing or only partially printed.
The affected lot is #0061852531, expiring 2/28/2025. Healthcare facilities and clinicians should immediately stop using the product and contact B. Braun Medical Inc. for return and replacement instructions.
The FDA classified this recall as Class III.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- B. Braun Medical Inc.
- Category
- Drug — Intravenous
- Hazard
- mis-labeling
- missing-warnings
- missing-instructions
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 0061852531
- Exp 2/28/2025
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · SODIUM CHLORIDE
- SevereFDA Class I Recall: B. Braun Sodium Chloride Injection for Particulate Matter
FDA (Drugs) · 2024-08-28
- HighSodium Chloride Injection Bags Recalled for Potential Leakage and Sterility Risk
FDA (Drugs) · 2023-07-19
- HighSodium Chloride Injection Recalled Due to Storage Temperature Exposure Risk
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Sodium Chloride Injection Due to Incomplete Container Seals
FDA (Drugs) · 2023-03-01
- HighSodium Chloride Injection Recalled for Incomplete Seal and Potential Leakage
FDA (Drugs) · 2023-03-01
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27